Dermatofibroma in a patient with Crohn's disease: a novel clinical manifestation.
Yavuz
Y
Beyazit
Sedat
S
Caner
Mevlut
M
Kurt
Murat
M
Kekilli
Gulden
G
Aydog
Mehmet
M
Ibis
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D018219:Histiocytoma, Benign Fibrous / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D012460:Sulfasalazine / Q000008:administration & dosage / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D012460:Sulfasalazine; D011239:Prednisolone